Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: A comparative immunohistochemical study by light and confocal microscopy

General and Comparative Endocrinology

Volumn 111, Issue 1, 1998, Pages 9-19

  Reddy, S ^a   Young, M ^a   Poole, C A ^a   Ross, J M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cytotoxicity; Diabetes; Glucose transporter; Insulin; cell

Indexed keywords

GLUCOSE TRANSPORTER; INSULIN; STREPTOZOCIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GLUCOSE TRANSPORT SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

EID: 0032127578     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1006/gcen.1998.7079     Document Type: Article

References (37)

1. Cooke A. An overview on possible mechanisms of destruction of the insulin-producing beta cell. Curr. Top. Microbiol. 164:1990;125-142.
2. Eisenbarth G. S. Type 1 diabetes mellitus: A chronic autoimmune disease. N. Engl. J. Med. 314:1986;1360-1368.
3. Eisenbarth G. S., Conelly J., Soeldner J. S. The "natural" history of type 1 diabetes. Diabetes Metab. Rev. 3:1987;873-891.
4. Elias D., Prigozin H., Polak N., Rapoport M., Lohse A. W., Cohen I. R. Autoimmune diabetes induced by the β-cell toxin STZ: Immunity to the 60-kDa heat shock protein and to insulin. Diabetes. 43:1994;992-998.
5. Ferrer J., Gomis R., Alvarez J. F., Casamitjana R., Vilardell E. Pancreatic islet glutz glucose transporter mRNA and protein expression in humans with and without NIDDM. Diabetes. 44:1995;1369-1374.
6. Ganda O. P., Srikanta S., Brink S. J., Morris M. A., Gleason R. E., Soeldner J. S., Eisenbarth G. S. Differential sensitivity to β-cell secretagogues in "early" type 1 diabetes mellitus. Diabetes. 33:1984;516-521.
7. Gerling I. C., Friedman H., Greiner D. L., Shultz L. D., Leiter E. H. Multiple low-dose streptozotocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Diabetes. 43:1994;433-440.
8. Inman L. R., McAllister C. T., Chen L., Hughes S., Newgard C. B., Kettman J. R., Unger R. H., Johnson J. H. Autoantibodies to the GLUT-2 glucose transporter of β cells in insulin-dependent diabetes mellitus of recent onset. Proc. Natl. Acad. Sci. USA. 90:1993;1281-1284.
9. Johnson J. H., Ogawa A., Chen L., Orci L., Newgard C. B., Alam T., Unger R. H. Underexpression of β-cell high Km glucose transporters in non-insulin-dependent diabetes. Science. 250:1990;546-549.
10. Jorns A., Teidge M., Sickel E., Lenzen S. Loss of GLUT2 glucose transporter expression in pancreatic beta cells from diabetic Chinese hamsters. Virchows Arch. 428:1996;177-185.
11. Kwon N. S., Lee S. H., Choi C. S., Kho T., Lee H. S. Nitric oxide generation from streptozotocin. FASEB J. 8:1994;529-533.
12. Leahy J. L. Natural history of β-cell dysfunction in NIDDM. Diabetes Care. 13:1990;992-1010.
13. Leahy J. L., Bonner-Weir S., Weir G. C. Beta-cell dysfunction induced by chronic hyperglycaemia: Current ideas on the mechanism of the impaired glucose-induced insulin secretion. Diabetes Care. 15:1992;442-455.
14. Like A. A., Rossini A. A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science. 193:1976;415-417.
15. Maclaren N. K., Neufield M., McLaughlin J. V., Taylor G. Androgen sensitization of streptozotocin-induced diabetes in mice. Diabetes. 29:1980;710-716.
16. Mandrup-Poulsen T., Helqvist S., Wogensen L. D., Molvig J., Pociot F., Johannesen J., Nerup J. Cytokines and free radicals as effector molecules in the destruction of pancreatic beta cells. Human Diabetes-Genetics, Environmental and Autoimmune Etiology. 1990;Springer-Verlag, Heidelberg. p. 169-193.
17. Ohneda M., Johnson J. H., Inman L. R., Chen L., Suzuki K-I., Goto Y., Alam T., Ravazzola M., Orci L., Unger R. H. GLUT2 expression and function in β-cells of GK rats with NIDDM. Dissociation between reductions in glucose transport and glucose-stimulated insulin secretion. Diabetes. 42:1993;1065-1072.
18. Orci L., Unger R. H., Ravazzola M., Ogawa A., Komiya I., Baetens D., Lodish H. F., Thorens B. Reduced beta-cell glucose transporter in new onset diabetic BB rats. J. Clin. Invest. 86:1990;1615-1622.
19. Rabinovitch A. Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Rev. 1:1993;215-240.
20. Reddy S., Bibby N. J., Fisher S. L., Elliott R. B. Longitudinal study of first phase insulin release in the BB rat. Diabetologia. 29:1986;802-807.
21. Reddy S., Bibby N. J., Elliott R. B. Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse. Diabetologia. 31:1988;322-328.
22. Reddy S., Elliott R. B., Poole C. A., Ross J. M. Double-label immunofluorescence study of glutamic acid decarboxylase in the fetal and adult ovine pancreas by light and confocal microscopy: evidence for predominant beta-cell coexpression. Gen. Comp. Endocrinol. 106:1997a;301-309.
23. Reddy S., Kaill S., Poole C. A., Ross J. Inducible nitric oxide synthase in pancreatic islets of the non-obese diabetic mouse: A light and confocal microscopic study of its ontogeny, co-localization and up-regulation following cytokine administration. Histochemical. J. 29:1997b;53-64.
24. Reddy S., Wu D., Elliott R. B. Low-dose streptozotocin causes diabetes in severe combined immunodeficient (SCID) mice without immune cell infiltration of the pancreatic islets. Autoimmunity. 20:1995a;83-92.
25. Reddy S., Wu D., Swinney C., Elliott R. B. Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse. Pancreas. 11:1995b;16-25.
26. Schnedl W. J., Ferber S., Johnson J. H., Newgard C. B. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes. 43:1994;1326-1333.
27. Slater T. F. Free radical mechanisms in tissue injury. Biochem. J. 222:1984;1-15.
28. Suarez-Pinson W. L., Strydnadka K., Rabinovitch A. Destruction of rat pancreatic islet β-cells by cytokines involved aldehydes. Endocrinology. 137:1996;5290-5296.
29. Srikanta S., Ganda O. P., Gleason R. E., Jackson R. A., Soeldner J. S., Eisenbarth G. S. Pre-type 1 diabetes: Linear loss of beta cell response to intravenous glucose. Diabetes. 33:1984;717-720.
30. Stubbs M., Guberski D. L., Like A. A. Preservation of GLUT2 expression in islet beta cells of Kilham Rat Virus (KRV)-infected diabetes-resistant BB/Wor rats. Diabetologia. 37:1994;1186-1194.
31. Thorens B. Molecular and cellular physiology of GLUT2 a high-Km facilitated diffusion glucose transporter. Int. Rev. Cytol. 137A:1992;209-238.
32. Thorens B., Weir G. C., Leahey J. L., Lodish H. F., Bonner-Weir S. Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic beta cells of diabetic rats. Proc. Natl. Acad. Sci. USA. 87:1990;6492-6496.
33. Thorens B., Wu Y-J, Leahy J. L., Weir G. C. The loss of GLUT2 expression by glucose-unresponsive β cells of db/db mice is reversible and is induced by the diabetic environment. J. Clin. Invest. 90:1992;77-85.
34. Tominaga M., Komiya I., Johnson J. H., Inman L., Alam T., Moltz J., Crider B., Stefan Y., Baetens D., McCorkle K., Orci L., Unger R. H. Loss of insulin response to glucose but not arginine during the development of autoimmune diabetes in BB/W rats: Relationships to islet volume and glucose transport rate. Proc. Natl. Acad. Sci. USA. 83:1986;9749-9753.
35. Wang Z., Gleichmann H. Glucose transporter 2 expression: prevention of streptozotocin-induced reduction in beta cells with 5-thio-D-glucose. Exp. Clin. Endocrinol. 103:1995;83-87.
36. Wilson G. L., Leiter E. H. Streptozotocin interactions with pancreatic β cells and the induction of insulin-dependent diabetes. Curr. Top. Microbiol. Immunol. 156:1990;27-54.
37. Zangen D. H., Bonner-Weir S., Lee C. H., Latimer J. B., Miller C. P., Hanbener J. F., Weir G. C. Reduced insulin, GLUT2, and IDX-1 in β-cells after partial pancreatectomy. Diabetes. 46:1997;258-264.